These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16819177)

  • 1. Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo.
    Okuda K; Kotake Y; Ohta S
    Biol Pharm Bull; 2006 Jul; 29(7):1401-3. PubMed ID: 16819177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
    Yamakawa T; Kotake Y; Fujitani M; Shintani H; Makino Y; Ohta S
    Neurosci Lett; 1999 Nov; 276(1):68-70. PubMed ID: 10586977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
    Munakata H; Ishikawa R; Saitoh T; Kambe T; Chiba T; Taguchi K; Abe K
    Can J Physiol Pharmacol; 2022 Jul; 100(7):594-611. PubMed ID: 35413210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
    Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination method of 1-methyl-1,2,3, 4-tetrahydroisoquinoline, an endogenous parkinsonism-preventing substance, by radioimmunoassay.
    Okuda K; Kotake Y; Ohta S
    Life Sci; 2002 May; 70(24):2871-83. PubMed ID: 12269399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
    Saitoh K; Abe K; Chiba T; Katagiri N; Saitoh T; Horiguchi Y; Nojima H; Taguchi K
    Pharmacol Rep; 2013; 65(5):1204-12. PubMed ID: 24399716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.
    Pietraszek M; Michaluk J; Romańska I; Wasik A; Gołembiowska K; Antkiewicz-Michaluk L
    Neurotox Res; 2009 Nov; 16(4):390-407. PubMed ID: 19649683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Pharmacol Rep; 2010; 62(6):983-97. PubMed ID: 21273655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
    Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
    J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson's disease.
    Wąsik A; Polak D; Romańska I; Michaluk J; Antkiewicz-Michaluk L
    Pharmacol Rep; 2016 Dec; 68(6):1205-1213. PubMed ID: 27657483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
    Kotake Y; Taguchi R; Okuda K; Sekiya Y; Tasaki Y; Hirobe M; Ohta S
    Brain Res; 2005 Feb; 1033(2):143-50. PubMed ID: 15694918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventative effects of 1,3-dimethyl- and 1,3-dimethyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on MPTP-induced Parkinson's disease-like symptoms in mice.
    Katagiri N; Chida S; Abe K; Nojima H; Kitabatake M; Hoshi K; Horiguchi Y; Taguchi K
    Brain Res; 2010 Mar; 1321():133-42. PubMed ID: 20114039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.
    Antkiewicz-Michaluk L; Wąsik A; Romańska I; Bojarski A; Michaluk J
    Neurotox Res; 2011 Aug; 20(2):134-49. PubMed ID: 21069490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.
    Wąsik A; Białoń M; Żarnowska M; Antkiewicz-Michaluk L
    Pharmacol Biochem Behav; 2019 Jun; 181():17-27. PubMed ID: 30965047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Przegaliński E; Vetulani J
    J Neural Transm (Vienna); 2007 Mar; 114(3):307-17. PubMed ID: 16897599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
    Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.